{"organizations": [], "uuid": "b4b093b1437e8785b2e0c761ab744c5b461174d2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-boya-bio-pharmaceutical-group-sub/brief-boya-bio-pharmaceutical-group-sub-subsidiary-receives-gmp-certificate-idUSL3N1R849Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Boya Bio-pharmaceutical Group sub-subsidiary receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.97, "site_type": "news", "published": "2018-03-26T19:11:00.000+03:00", "replies_count": 0, "uuid": "b4b093b1437e8785b2e0c761ab744c5b461174d2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-boya-bio-pharmaceutical-group-sub/brief-boya-bio-pharmaceutical-group-sub-subsidiary-receives-gmp-certificate-idUSL3N1R849Z", "ord_in_thread": 0, "title": "BRIEF-Boya Bio-pharmaceutical Group sub-subsidiary receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-boya bio-pharmaceutical group", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "reuters) - boya bio-pharmaceutical group co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "jiangxi food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Boya Bio-pharmaceutical Group Co Ltd :\n* Says its sub-subsidiary received goods manufacture practice (GMP) certificate from Jiangxi Food and Drug Administration\n* Certificate issued calcium dobesilate manufactured by the unit and the valid period is until March 20, 2023\nSource text in Chinese: goo.gl/EspCbb\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/EspCbb", "https://instagram.com/reuters/"], "published": "2018-03-26T19:11:00.000+03:00", "crawled": "2018-03-27T12:14:48.073+03:00", "highlightTitle": ""}